Trials / Completed
CompletedNCT02521506
Clinical Efficacy of OneTouch® Verio™IQ Meter
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Fundación Pública Andaluza Progreso y Salud · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Diabetes mellitus is one of the most prevalent disease in the western world. The control of glucose levels has a big impact in the prevention of diabetes complications. The measure of glucose levels in capillary blood with glucometers is the gold standard to measure and control the glucose levels. Nowadays the glucometers become to more precise and sophisticated devices. One of the most notables advance is the inclusion of software that cam predicts glucose trends. This software has not be tested in routine clinical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Verio Pattern Alert® activated | |
| DEVICE | Verio Pattern Alert® deactivated |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-08-13
- Last updated
- 2017-03-07
Locations
4 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02521506. Inclusion in this directory is not an endorsement.